CBN Complete Guide — Dose, Combinations, Timing, and What to Look for on the Label
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. SleepDosingResearchSafetyIndustryHempPolicy Why This Matters Clinicians need to understand that most commercially…
The #TerpeneSeries is back Camphene is one of the many terpenes found in cannabis …
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ResearchHempTHCCBDSafetyIndustryAnxiety Why This Matters Clinicians should understand that terpenes like camphene…
German Cannabis Market Study: Rising THC, Dropping Prices
✦ New CED Clinical Relevance #77 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. THCResearchIndustryPolicyPainSafetyDosing Why This Matters Clinicians prescribing cannabis in regulated markets need…
Is VER-01 a Turning Point for Cannabis-Derived Medicines?
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ResearchCBDTHCSafetyNeurologyIndustryPain Why This Matters Clinicians need to understand that pharmaceutical cannabinoids…
Medicinal Cannabis Matters: Friday Roundup – 24 July 2026
✦ New CED Clinical Relevance #72 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. PolicySafetyResearchDosingIndustryMental HealthPain Why This Matters Clinicians need to understand international travel…
Georgia’s medical cannabis program surpasses 40,000 patients, with more than 10 …
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. PolicyPainSleepAnxietyMental HealthTHCIndustry Why This Matters Georgia's rapidly expanding medical cannabis patient…
Oklahoma Watch: Marijuana testing hampered by lack of consistency, lab shopping
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. PolicySafetyIndustryResearchTHCHempCBD Why This Matters Variable testing standards across Oklahoma's cannabis labs…
What Makes VER-01 Unique Among Cannabis-Derived Pain Therapies?
VER-01 exemplifies pharmaceutical-grade CBD products by offering standardized, reproducible dosing unlike traditional cannabis-derived pain therapies. This approach may improve clinical outcomes by reducing variability and enhancing safety.…
Ananda Pharma Doses First Patient in NIHR-Backed CIPN Trial
✦ New CED Clinical Relevance #77 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. PainCancerNeurologyResearchDosingSafetyIndustry Why This Matters This trial represents a rigorous clinical pathway…
Review Finds Nanoencapsulation Could Improve Cannabinoid-Based Pain Treatments
✦ New CED Clinical Relevance #77 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. PainResearchCBDTHCSafetyDosingIndustry Why This Matters Nanoencapsulation technology could enable more reliable and…